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ABSTRACT
The pharmacy industry is experiencing significant change. With the increasing presence of
regional discounters, ihe appearance ofmail service and internet pharmacies, the continuing
ascendancy ofmanaged care (including HMOs and PPOsj, third party reimbursement plans,
anil pharmacy benefit managers (PBMsj, the strategic options for independent pharmacies
are dwindling. This exploratory study examines the relationships among geneiqc business
level strategies of independent pharmacies, industry effects —in terms of consequences of
third party reimbursement plans —and performance outcomes. It seems that the impact of
managed care reimbursements more than offsets tiie various strategic efforts by pharmacies.
The evidence indicates that different generic strategy approaches are not producing
significant differences in performance. The findings suggest that industry effects may be
creating a situation of ctraiegic convergence. The practical implications for theindependent
pharmacists and future research are addressed.
INTRODUCTION
THE CHANGING FACE OF THE PHARMACY INDUSTRY
Independent pharmacies, like many other businesses, are faced with a rapidly changing
competitive environment, which could be classified as very turbulent (Harrison & Ortmeier,
1997). The increasing presence of regional discounters, the availability of mail service and
internet pharmacies, the continued ascendancy of managed care (including HMOs and PPOs),
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third party reimbursement plans, and pharmacy benefit managers (PBMs) are reshaping the
pharmacy industry. These environmental changes are placing intense demands on
independent pharmacies, those privately held, usually owner-operated, pharmacies that are not
affiliated with any chain (Beliveau & Bernstein, 1997).
Industry context continues to be a major determinant of a firm's success and survival
(Sandberg &. Hofer, 1987). Using a deterministic perspective, a pharmacy's strategy and
performance may be primarily determined by industry effects, those attributes common to an
industry (Stratton &. Martens, 1994). In particular, third party reimbursement plans are an
element which has had long-term detrimental eITects on pharmacy profits (Frederick, 2001b;
Carroll, 1991). While independent pharmacists have seen increases in gross sales revenues
and in the numbers of prescriptions filled (West, 2001), third party plans are depressing the
profitability of independent pharmacies.
This study examines the relationships of the generic business strategies of independent
pharmacies, industry effects, in terms of consequences of third party reimbursement plans,
and performance outcomes. Performance is measured in terms of self-reported financial
returns and a composite measure of overall success. The evidence suggests that diITerent
generic strategies are not producing significant differences in perceived performance. Not
surprising is the finding that third party reimbursement plans significantly and negatively
affect independent pharmacies'erceived performances. The research supports the argument
that industry eITects may be creating a situation of strategic convergence where pharmacies
are copying the strategies of their competitors in order to succeed. The implications for both
practitioners and future research are discussed.
STRATEGIC OPTIONS
Under upper-echelons theory, managers matter a great deal, depending upon how much
discretion or latitude of action they possess (Cannella, 2001; Finkelstein & Hambrick, 1996:
Hambrick & Mason, 1984). Independent pharmacists who are usually owner/operators should
possess considerable discretion in setting the strategy and course for their firms. However,
discretion exists only in the absence of constraint; it emanates from the business's
environment, the organization itself, and from the executives. For an independent pharmacy,
the industry environment is a likely constraint upon the choices available to the
owner/operator in craiting strategies. Where managers are constrained and their choices
restricted, the economic differences among them may not be so great (Cannella).
Generic Strategic Options
While recent research, particularly the resource based view, has concentrated on firm-level
attributes, generic business strategies remain useful in characterizing strategic positions of
firms at the simplest and broadest level (Porter, 1996). The generic strategies framework
continues to highlight the inherent contradictions of different strategies and the tradeoffs
which must be made by managers in implementing their strategic choices (Hodgetts, 1999;
Porter).
The generic business strategies, as identified by Porter (1980), include overall low cost
leadership and differentiation (see Figure I). A low cost leadership strategy comprises an
internal orientation on product efficiencies and cost control. Cost savings can be achieved by
minimizing expenditures on innovation and advertising and offering no-frills rather than
concentrating on image and brand name products. Differentiation strategies endeavor to offer
customers unique products or services. Miller (1988) identified two distinct types of
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differentiation: marketing and innovation. Extensive advertising and image management and
intensive marketing, such as offering attractive features, convenience, and service guarantees
characterize marketing differentiation. Innovative differentiators are characterized by
creativity in product offerings, application of new technologies or products, and current
innovations (Dess, Lumpkin & Covin, 1997). In the past, smaller firms, with limited
resources, skills, and capabilities, were advised to adopt narrower differentiation strategies, or
niche strategies, which focus on specialized products or services for targeted markets (Broom
& Longnecker, 1979).
Figure 1
Generic Competitive Strategies
TYPE OF COMPETTIVE ADVANTAGE
Low cost Differentiation
Overall Broad
Low-Cost Differentiation
of Buyers Leadership -—- Strategy
Hybrid
A Narrow ralegies
Buyer Segment0 Focused Focused
(or Market Niche) Low-Cost Differentiation
Strategy Strategy
Historically, independent pharmacists have adopted differentiation strategies to gain
competitive advantage. Pharmaceutical care generally incorporates three components of
cognitive services: dispensing services, dispensing-related services, and non-dispensing value-
added services (Christensen, Fassett & Andrews, 1993). Differentiation was previously
gained by offering non-dispensing value-added services (Bouldin, Bentley, Huffman &
Garner, 1996). Most pharmacists now offer a wide variety of non-dispensing value-added
services, which have blurred the distinctiveness and uniqueness amongst pharmacies
(Frederick, 2001a, 2001b). The wide ranges of services which pharmacists can provide are
changing their roles and providing opportunities for competitive advantage and commensurate
improved performance. Pressure is placed upon pharmacists to involve consumers in their
pharmaceutical care (Holdford & Watrous, 1997). Pressure to inform consumers of price and
cost differences among products originated in part as a result of third party reimbursement
plans'ttempts to control rising costs (Szeinbach, Bames, Summers & Banahan, 1995).
Further, for the individual consumer, co-payment policies of third party plans have removed
price as a competitive weapon. As the expansion of third party reimbursements creates
greater competition in the pharmacy industry (Genuardi, Stiller, & Trapnell, 1996),
pharmacists in order to be successful in this new environment must position their businesses
to meet or satisfy most or all of the needs of their customers.
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Industry Constraints
Industrial organization economics (I/O economics) posits that strategy and performance are
determined primarily by membership in an industry. Industry effects pertain to the attributes
customary to an industry. The dominance of industry effects within an industry demonstrates
the similarities by which companies in that industry respond to industry conditions and their
imitation of successful strategies (Mauri & Michaels, 1998). Regardless of the school of I/O
economics (Bain/Mason, Schumpeterian, or Chicago), the I/O economics literature generally
assumes that firms within an industry will be homogeneous in terms of their patterns of
competitive behavior (Mauri & Michaels).
The rapid growth of third party prescription reimbursement plans is changing the dynamics of
the pharmacy industry. Third party reimbursement programs play an increasing role in the
prescription drug market, now accounting for over 80% of the prescriptions dispensed in the
entire retail setting (Frederick, 200lb). As a result of cost containment efforts and the
preeminence of third party plans, independent pharmacies have experienced decreases in
dispensing fees and corresponding decreases in gross profit margins. Third parties (managed
care groups and PBMs) are offering pharmacies contracts with smaller dispensing fees, and
some have even closed their networks, effectively excluding some pharmacies. Consequently,
independent pharmacies can either accept decreasing levels of reimbursement for services or
be excluded from some plans. Although third party reimbursement programs appear to have a
detrimental effect on profit margins, retail pharmacists continue to provide these prescription
services for fear of losing business to competitors (Szeinbach et al. 1990). A previous study
by Carroll (1991)predicted that third party reimbursement programs would have a detrimental
effect on the profits of independent pharmacies. Anecdotal evidence from discussions with
independent pharmacists indicates that performance is negatively affected by third party
reimbursements.
Third party reimbursement plans have effectively eliminated price as a competitive weapon.
The consumer has become price indifferent because the out of pocket cost of a prescription is
offen the same regardless of the pharmacy. For example, under a typical employer drug plan,
the consumer pays $30.00 for a name-brand prescription, $20 for a generic. Regardless of
which pharmacy she chooses, she will be responsible for only the co-payment. What the
pharmacist receives is determined by the contract between the pharmacist and the third party
payor. This arrangement removes price as a strategic option, leaving only diITerentiation of
services to the pharmacist's discretion.
Where managers are constrained and their choices restricted, the economic differences among
them may not be so great (Cannella, 2001). We hypothesize that faced with an external
environment which restricts pharmacists'pportunities by limiting their strategic choices
(Szeinbach, et al., 1995), and with the limitations imposed by their size, the performances
among independent pharmacies will not be appreciably different.
METHODOLOGY
Survey Procedures
The data concerning the operations of the independent pharmacies was collected by a
questionnaire. The questionnaire was adapted from earlier works on the strategies, marketing
decisions, and competitive methods of small independent retailers (McGee & Peterson, 2000;
Conant, Smart, & Solano-Mendez, 1993). The questionnaire was pre-tested by three
independent pharmacists (not included in the final sample) to determine if there were
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problems interpreting any of the questions. No problems were detected by the pre-test
participants who had no difficulty answering the questions or rating the performance of their
pharmacies. The comments of the pre-test participants were incorporated into the
questionnaire.
The sample of independent pharmacies was compiled from a list of all licensed pharmacies
supplied by a southwestern state's pharmacy board. An independent pharmacy is defined as
privately held, usually owner-operated, and not affiliated with any chain (Beliveau &
Bernstein, 1997). Pharmacies identified with national or regional chains (108) were deleted,
and the survey instrument was mailed to a final sample of 528 pharmacies. The questionnaire,
along with a stamped return envelope, was addressed to the licensed pharmacist at each
location. Reminder postcards were sent approximately three weeks later. A total of 88
responses were returned, for a response rate of 16.67'/o.'he responses indicated that
qualified informants answered 97.4'/n of the survey instruments: 81.7'/a were answered by the
owners of the establishments, and 15.7'/o by the pharmacist in charge of the pharmacy. The
respondents, the owners or pharmacists in charge, should be aware of the operations and
performances of the pharmacies. The responses of 13 pharmacies provided incomplete
performance information and were deleted from the final analysis.
Non-response bias occurs when the opinions and perceptions of the survey respondents do not
accurately represent the overall sample to which the survey was sent. One test for non-
response bias is to compare the answers of early versus late respondents to the survey. The
idea is that late respondents are more likely to answer the questionnaire like non-respondents
than are early respondents (Armstrong & Overton, 1977). A multivariate t test was computed
using the key study variables in order to examine whether significant differences existed
between early and late respondents. The results indicated that early respondents do not display
statistically significant differences from late respondents (p&.05)(Miles &. Arnold, 1991).
Definition of Variables
One section of the questionnaire asked what generic business strategies the pharmacies
emphasized. Previous research (Dess, et al., 1997; Miller, 1988) has identified three distinct
generic business strategies (cost leadership, innovative differentiation and marketing
differentiation). The measure of the generic business strategies was conducted using a scale
similar to the scale developed by Miller (1988) in studies of manufacturing firms. The scale
was developed from questions regarding the importance of specific business strategic tactics
and included two cost leadership items, two innovative differentiation items and three
marketing differentiation items. Respondents were asked to indicate the degree to which they
emphasized certain strategic tactics on a Likert-type scale from I = "very unimportant" to 7 =
"very important." Factor analysis was used to identify the particular strategies of the
pharmacists. The seven strategy items were factor analyzed using a principal components
analysis with varimax rotation. All factor loadings were greater than .50 which indicates that
they are very significant (Hair, Anderson, & Tatham, 1987).
The performance of the independent pharmacies is operationalized using subjective self-report
measures. Phaimacists were asked to compare their pharmacies'erformances against their
competitors along four dimensions: gross profit [Gross Profit], net income after taxes [Net
Income), total sales growth over the past 3 years [Sales Growth], and overall pharmacy
performance/success [Overall Success]. Previous research has shown that subjective
measures of performance are consistent with objective measures, thus enhancing the
reliability and validity of these measures (Dess, et al., 1997; Venkatraman & Ramanujam,
1987; Dess &. Robinson, 1984). The questionnaire sought objective measures of performance,
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but fewer than half of the respondents provided any of the requested information. Financial
measures of performance may be inappropriate for small businesses and family-owned
businesses, because the roles and objectives of small business owners make the attribution of
success for small businesses complex, dynamic, and problematic (Jennings & Beaver, 1997).
Small business success may, indeed, be the sustained satisfaction of the principal
stakeholders'spirations (Jennings & Beaver). Therefore, success in the perception of the
owner/operator is an appropriate measure, as well as the use of a composite score. Previous
research has suggested that traditional measures of performance may not be appropriate for
pharmacies, and that a "benchmarking" performance measure should be used as another
nonfinancial performance measure (Stratton & Martens, 1994). Comparing a
business'erformance
against the performances of its competitors is the basis for an additional
measure. A comparative measure was adduced by adding together the responses of the four
dimensions described previously. A scale which sums the four performance perceptions
supplied an appropriate benchmark measure [Sustainability], Cronbach's alpha = .8225, which
is an acceptable measure of internal consistency.
The industry context is dominated by third party reimbursement plans and this was used as a
proxy for the industry effects in the regression equations. Third party reimbursements are the
percentage of prescriptions paid for by third party managed care payors [Third party %]. Size
has also been identified as a factor in pharmacy operations and performance (Beliveau &
Bernstein, 1997), and was controlled for in this study. Size was operationalized by using the
weekly average number of prescriptions filled [Size]. A description of the variables and their
sources are set forth in Table I.
Table I —Variables
Name Source
independent Variables
Marketing Differentiation Factor Analysis
Innovation Differentiation Factor Analysis
l.ow Cost Leadership Factor Analysis
Control Variables
Third Party Reimbursements Questionnaire Answer:
Percentage of prescriptions paid by third-parties
Size Questionnaire Answer:
Number of prescriptions filled weekly
Dependent Variables
Gross Profit Self-report measure - Likert-type answer
Net Income Atter Taxes Self-report measure - Likert-type answer
Total Sales Growth atter 3 years Self-report measure - Likert-type answer
Overall Pharmacy Performance/Success Self-report measure - Likert-type answer
Scale measure created by combining
Sustainability
responses to 4 prior performance measures
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Methods of Analysis
The research consisted of two phases. First, the responses concerning generic business
strategies were factor analyzed. In the next phase, regression analyses were used to test the
hypotheses concerning the performance implications of the business strategies and the
industry effects. The basic form of the regression equation model is:
Y=a+bX+cZ,+dZ,
where
Y = the performance variable [Gross Profits, Net Income, Sales Growth, Overall
Success, and Sustainability]
+a = intercept
+ X = business strategy
+ Zi = third party reimbursement [Third party %]
+ Zs = size [Size]
RESULTS
Table 2 sets forth the descriptive statistics and the correlation matrix for the pharmacies that
responded to the questionnaire. Included in the correlation matrix are the factor scores
generated by SPSS for the three generic business strategies. The average pharmacy in the
study has; 1.77 pharmacists; 1.50 technicians; 5.83 employees; is 16.61 years old; and has a
total square footage of 2316 of which 648 square feet (39%) is devoted to the prescription
department. The average pharmacy fills 698 prescriptions weekly. Third party plans
constitute a large percentage of business done by independent pharmacies (57.10%),a finding
which corresponds to national trends at the time of the survey (Fleming, 1998). Average
annual sales are $ 1.145 million.
Table 2 —Descriptive Statistics and Correlations
hlean S.O. Cross Nei Saler Overall Success/Profit Income Crowrb Performance abilio
Gross Profit 4.26 1.39 1.000
Net Income (AT) 4.00 1.42 .794"'.000
Totnl Sales Growlh Over
5 00 147 357rr ~ 439v ~ ~ I 000Past 3 Years
Overnll perf./Success 5.03 1.40 .462vv .523vv ~ .745~ v ~ 1.000
Survivability 18.25 4.63 .789"'847"'769vvv .826v'v 1.000
Innovative Strategy '.061 .137 .005 .014 .028
Low Cost Strategy '.075 .072 -.052 .044 .000
Differentiation Strategy'001 -.111 .222 .043 .064
690.3 448.6 .041 .162 .107 .123 .133prescriptions filled/week)
Third Pany
.56 .14 -.346vv'.369vvv -.200v -.181 -.319r mReimbursements (%)
5('ol'es golicl"iteil I'rom lector aiudysis
—Signilic uit Oo .Ol '* —Sist titic utt (P .05 ' Siguificani 4b .10
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Business Strategy Results
As expected, the factor analysis yielded three patterns of strategic behavior: marketing
differentiation, innovative differentiation and cost leadership, each with eigenvalues greater
than one (see Table 3). Factor one most closely aligns with a marketing differentiation
strategy. Historically, independent pharmacists have attempted to create a competitive
advantage through the services they offer. Factor one identifies pharmacies which attempt to
best their competitors by extensive use of advertising and lowering their prices. The second
factor closely aligns with an innovation differentiation strategy, where the
pharmacists'trategy
is to offer innovative products and services. Factor three encompasses strategies for
cutting costs, coexisting with competitors, and not spending excessively to differentiate their
businesses. This strategy does not stress innovation or trying to compete with methods
identified with factors one and two. All of the seven items loaded (factor loadings & .50).
Table 3 - Factor Analysis of Business Strategies of Independent Pharmacists (n=85)
Factor Loadings
BUSINESS STRATEGIES
Marketing Differentiation
Try to Beat Competitors .737
Cut Prices to Remain Competitive .743
Extensively use advertising .708
innovation Differentiation
Favor growth and innovation .860
Use Service Innovations .839
Low Cost Leadership
Coexist with Competitors .862
Cut Costs .757
EIGENVALUES 1.664 1.492 1.474
Cumulative percent of variance explained 23.769 45.089 66.145
Cronbach's Alpha '9.44 65.33 57.71
Kaiser-Mayer-Olkin measure of Sampling Adequacy = .636
The regression analysis revealed that three of the models were significant: Gross Profit, Net
Income, and Sustainability. However, none of the strategies were found to contribute to the
explanation of pharmacy performance. Interactions between the identified generic business
strategies and third party reimbursements (generic strategy X third party %) were also tested,
and none of the interactions were significant predictors in any of the five regression models.
3
In addition, the strategies did not significantly correlate with any of the performance
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measures. These findings support the study's hypothesis that performance differences among
independent pharmacies are not significantly different.
As expected, in explaining pharmacy performance, third party reimbursement programs were
the only significant predictor. The percentage of third party reimbursements is negatively
associated with Gross Profits, Net Income, and Sustainability, the benchmark performance
measure (p &= .Ol). Further, the third party reimbursement coefficient was statistically
significant (p &= .05) and negative in all five regression equations. These findings are
consistent with the prediction of prior research (Carroll, 199I). These results also support the
anecdotal claims of the pharmacists in the pre-test who bemoaned the negative influence of
third party arrangements on their operations, strategies, and profitability. The regression
results were similar to the output for the correlation analysis; that the only significant
relationships were between third party reimbursements and the dependent measures of
performance.
DISCUSSION AND IMPLICATIONS
In exploring the performance of independent pharmacies, this research finds that despite
differences in the generic business strategies which were followed, the differences in their
performances were not statistically significant. In the past, pharmacies relied upon
differentiation strategies to gain competitive advantage (Bouldin, et al., l 996). However,
none of the differentiation strategies used by the responding pharmacies was effective in
creating competitive advantage, i.e., superiority in performance outcomes. The challenge for
the independent pharmacist in a dynamic and turbulent environment is to operate more
efficiently, while offering differentiated or unique services in order to compete against the
powerful chains and drug discounters. Prior research has shown that combination or hybrid
strategies of low cost and differentiation may be successful for retailers (Rubach & McGee,
2002). The factor analysis suggests that pharmacies may be pursuing combination strategies.
The findings also suggest a convergence or homogeneity of strategic behaviors: regardless of
the strategy, there are no significant differences in performance outcomes. Industry elfects,
not firm-level strategies, determine a pharmacy's performance. Industrial organizational
economics and the resource-based view of the flrm are complementary, not contradictory,
theories (Mauri & Michaels, 1998). While other theories, such as the resource-based view of
the firm, may offer explanations for the performance differences among pharmacies, the
examination of industry effects is still relevant. Industry effects are a complement to other
theories and aid in explaining why some firms succeed and others fail. The models of
competitive advantage that measure particular resources, capabilities, routines, and processes
may impact the explanation of the differences in pharmacy performance. However, industry
effects cannot be ignored. It is clear that independent pharmacies are adversely affected by
third party reimbursements. In order to prosper, independent pharmacists will have to change
their operations and strategies, increase their skills and knowledge, and better serve their
customers. Given the changing face of the pharmacy industry, the operations of independent
pharmacies will likely be quite different in the near term.
The pharmacy business is a needs-based industry, similar to needs-based industries such as
hardware stores and automobile parts stores. All of these industries are facing pressures from
their changing industry environments. In response to these changes, we do not wish to
suggest that the owner/operator is without strategic recourse. The challenge faced, however,
is to operate more efficiently, while offering differentiated or unique services in order to
compete against the powerful chains and category discounters Service will continue to be the
keystone which can make pharmacies unique. Offering personalized services can differentiate
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the independent pharmacist from the chain store. Benchmarking services and performance
not only against other pharmacists, but also against other needs-based industries may be a
necessity. There are alternatives for pharmacists: creating strategic alliances with other
independents to gain buyer power (e.g., buying cooperatives), and with care providers (e.g.,
nursing homes); reducing staffing costs by utilizing pharmacy technicians, and providing, and
charging for, drug therapy and counseling services, especially disease management services
(Frederick, 2001a, 2001b).
This study is not without limitations. The method used to measure performance was financial
in its scope. Perhaps survival by an independent pharmacy is a better measure. An average of
1,884 independent pharmacies closed yearly during the period of 1990 to 1993 (Frederick,
2001a), but it appears the precipitous decline in independent pharmacies nationwide had
finally subsided by the close of the millennium. There were increases in the number of
independent pharmacies during the year 2000 (Frederick, 2000). Future research should
examine this change and its causes.
The low response rate and consequent small sample could conceivably limit the
interpretability of findings because of the increased probability of not detecting a relationship
between variables where one actually exists. Although we provided evidence that non-
response bias was not a major problem in the study, we cannot be assured that the non-
respondents did not differ in important ways from the respondents. Although it is unlikely
that sample selection bias drove these results, they should be replicated for more confident
generalization. Further, the study is limited in its scope and analyses. It studies only one
industry, and industry dynamics that may be peculiar to only the health care industry. The
methodology used financial measures. There are disadvantages in using self-report subjective
measures, which have been addressed elsewhere in the literature. The study also is cross-
sectional, as opposed to a longitudinal study, which may be better suited to studying the
eITects of the issue of pharmacy performance, especially if survivability is an appropriate
measure. Lastly, this study is exploratory in nature. There are additional issues that may
affect pharmacy performance, including the study and analysis of more finely grained
constructs such as marketing strategies, competitive methods, distinctive competencies, and
the perceptions of customers of these services.
CONCLUSION
As the health care industry becomes more bureaucratized through managed care, third party
insurance contracts, and pharmacy benefit managers, the demands on pharmacists will
increase. There is growing pressure on pharmacists to be customer-focused and to keep
better-educated consumers informed of all alternatives. Third party reimbursement plans, in
turn, are foreclosing price as a strategic alternative. It is unlikely that the industry will back
away from cost-containment, and in fact, independent pharmacists expect new measures to
further contain costs (Fleming, 1998). Within this mature industry, pharmacists are pressured
to provide unique customer-focused services (Beliveau, Bernstein, & O'eill, 1994). This
will likely entail a reevaluation and modification of the roles of pharmacists toward more
involvement in patient care, education, and counseling (Reda, 1997). With the changing roles
will come changes in operations and strategies.
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ENDNOTES
While the response rate is not optimal, it does represent 16.67%of the total population of
independent pharmacies located in one state. The questionnaire sought responses from the
owner/operators of the pharmacies. This research is similar to other research concerning top
managers and company executives where response rates are notoriously low. Responses rates
of less than 20% are acceptable in this type of research; a 18% response rate (Milliken,
Martins, & Morgan, 1998), a 13.6 % response rate (Agle, Mitchell, & Sonnenfeld, 1999);and
even a 6% response rate (Simons, Pelled, &. Smith, 1999)were acceptable.
Further, where lengthy questionnaires are used, such as in this study, response rates can be
typically quite low. Studies with response rates of 22% (Mirani & Lederer, 1998), 11.2%
(Carter, 2000), and 17 % (Martin, Beaumont & Staines, 1998) have been acceptable under
these circumstances.
To test the reliability of the strategy constructs, coefficient alphas were calculated for the
items loading on each factor. They were as follows: innovative differentiation strategy
(.6533); marketing differentiation strategy (.5944); and low cost leadership strategy (.5771).
These reliability measures are marginally below desired levels (Nunnally 1978). The
coexistent environmental pressures to lower costs and be more efficient, and simultaneously
be unique may be the cause of these less than optimal reliabilities. Local merchants often find
it difficult to articulate their strategies and in dynamic environments they have been found to
adopt hybrid or combination strategies (Rubach & McGee, 2002). While the reliabilities are
less than optimal, they are useful in measuring a pharmacist's generic business strategy in
exploratory research of this nature.
'n order to save space and because the findings are insignificant, they are not reported. The
results of this analysis are available upon request of the lead author.
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